Delivery Order SPE2DB20D3103-SPE2DB24FP8S6
Award Date
8/12/24
Potential Completion Date
8/13/24
Potential Value
$35K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,341.67 firm fixed-price delivery order is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of April 25, 2024 and was awarded on April 24, 2024. This award is a child contract under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $14,548.55, is for the delivery of Otezla 30 mg tablets. It is a firm fixed-price delivery order contract with a completion date of September 26, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $15,807.33, is for the delivery of Otezla 30 mg tablets. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of March 6, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,416.90 firm fixed-price delivery order is for the supply of Otezla 30mg tablets. The contract has an ultimate completion date of October 18, 2024. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $18,112.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Otezla 30 mg tablets, a medication used to treat certain medical conditions. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is a delivery order valued at $1,985.54 for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,846.82 firm fixed-price delivery order contract is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of June 27, 2024. Amerisourcebergen is the prime contractor and holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $25,094.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Otezla 30 mg tablets, a medication used to treat certain medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of May 2, 2025. This award is not designated as a set-aside contract, indicating open competition....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $57,056.79, is for the delivery of Otezla 30 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 4, 2024. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,163.40, is for the delivery of Otezla 30 mg tablets. This is a firm fixed-price delivery order contract with a completion date of January 8, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA...